Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine infusion during elective abdominal aortic aneurysm repair
IRCT20190121042444N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine in abdominal aortic aneurysm (AAA) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Relative level of IL-6 mRNA, Relative level of TNF-alpha mRNA and 5 more. Started Jul 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on IRCT20190121042444N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190121042444N1.